Osman Kibar is the CEO of Samumed, which recently hauled in a $438 million funding round. Samumed led the pack among a spate of large life sciences investments. File photo by Jamie Scott Lytle


Sheila Gujrathi is the CEO of Gossamer Bio. The company has raised $330 million this year, evidence of a hot San Diego life sciences landscape. Photo courtesy of Gossamer Bio

— Cash is pouring into early-stage San Diego life sciences, with 2018 shaping up as a banner year, according to observers...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129